![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an o... Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex. Show more
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.31 | -15.4228855721 | 2.01 | 2.16 | 1.67 | 175356 | 1.87522813 | CS |
4 | -0.48 | -22.0183486239 | 2.18 | 2.45 | 1.67 | 174217 | 1.9898934 | CS |
12 | -0.12 | -6.59340659341 | 1.82 | 2.95 | 1.67 | 146155 | 2.05983106 | CS |
26 | -0.11 | -6.0773480663 | 1.81 | 2.95 | 1.67 | 177526 | 2.0359603 | CS |
52 | -1.1 | -39.2857142857 | 2.8 | 2.98 | 0.9001 | 162239 | 1.87080559 | CS |
156 | -10.45 | -86.0082304527 | 12.15 | 13.8 | 0.9001 | 163901 | 3.03400464 | CS |
260 | -10.45 | -86.0082304527 | 12.15 | 13.8 | 0.9001 | 163901 | 3.03400464 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions